INDV - Indivior Pharmaceuticals Inc
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$44.67
DETAILS
HIGH:
$50.00
LOW:
$36.00
MEDIAN:
$48.00
CONSENSUS:
$44.67
UPSIDE:
19.02%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 80.1% |
| EBIT Margin | 22.9% |
| EBITDA Margin | 24.5% |
| Operating Margin | 21.4% |
| Pretax Margin | 19.3% |
| Cont. Ops Margin | 16.9% |
| Net Margin | 16.9% |
| Bottom Line Margin | 16.9% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 0.71 |
| Quick Ratio | 0.55 |
| Solvency Ratio | 0.177 |
| Cash Ratio | 0.21 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings | |
| PEG Ratio | 0.00 |
| Forward PEG | 0.00 |
| Price/Book | -45.77 |
| Price/Sales | 3.62 |
| Price/FCF | -48.23 |
| Price/Op Cash Flow | -166.11 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.2915 |
| Debt/Equity | -3.5816 |
| Debt/Capital | 1.3874 |
| Long-Term Debt/Capital | 1.5104 |
| Financial Leverage | -12.29 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | -6.85 |
| Operating Cash Flow Ratio | -0.030 |
| Operating Cash Flow/Sales | -2.2% |
| Free Cash Flow/Operating Cash Flow | 344.4% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | 3.27 |
| Interest Coverage | 5.8889 |
| Short-Term Operating Cash Flow Coverage | -0.69 |
| Operating Cash Flow Coverage | -0.08 |
| Capital Expenditure Coverage | -0.41 |
| Dividend + Capital Expenditure Coverage | -0.41 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 9.91 |
| EPS | 1.680 |
| Debt/Share | 3.1680 |
| Cash/Share | 1.56 |
| Book Value/Share | -0.78 |
| Tangible BV/Share | -0.80 |
| Equity/Share | -0.78 |
| Operating Cash Flow/Share | -0.216 |
| Capital Expenditure/Share | 0.528 |
| FCF/Share | -0.744 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 0.879 |
| Earnings Before Tax/EBIT | 0.902 |
| Price/Fair Value | -45.77 |
| Debt/Market Cap | 0.0734 |
| Effective Tax Rate | 12.1% |
| Enterprise Value Multiple | 15.27 |